Expression analysis of extracellular microRNA in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis

被引:28
|
作者
Kishore, Amit [1 ]
Navratilova, Zdenka [1 ]
Kolek, Vitezslav [2 ]
Novosadova, Eva [1 ]
Cepe, Klara [3 ]
du Bois, Roland M. [4 ]
Petrek, Martin [1 ]
机构
[1] Palacky Univ, Fac Med & Dent, Dept Pathol Physiol, Hnevotinska 3, Olomouc 77515, Czech Republic
[2] Palacky Univ, Fac Med & Dent, Dept Resp Med & TB, Olomouc, Czech Republic
[3] Palacky Univ, Fac Sci, Olomouc, Czech Republic
[4] Imperial Coll, London, England
关键词
bronchoalveolar lavage; exosomes; microRNA; microvesicles; pulmonary sarcoidosis; ALLERGIC AIRWAY INFLAMMATION; LUNG; EXOSOMES; CELLS; RESPONSES; DISEASE; IMMUNE; MIRNA;
D O I
10.1111/resp.13364
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective MicroRNA (miRNA) are transcriptional regulators implicated in pulmonary sarcoidosis and packaged in extracellular vesicles (EV) during cellular communication. We characterized EV and investigated miRNA expression in bronchoalveolar lavage (BAL) fluid from sarcoidosis patients. Methods EV were characterized for size(s) using dynamic light scattering and transmission electron microscopy (TEM) analysis and protein markers by immunoblotting. Twelve extracellular and 5 cellular miRNA were investigated in BAL from 16 chest X-ray stage-I (CXR-I) and 17 CXR stage-II (CXR-II) sarcoidosis patients. Associations between miRNA and disease characteristics (extrapulmonary involvement, pulmonary function and BAL cell profile) were statistically analysed. Results BAL from sarcoidosis patients contained exosomes and microvesicles (MV) as EV. In these EV, expression of miR-146a (P = 0.007), miR-150 (P = 0.003) and BAL cellular miR-21 (P = 0.01) was increased in CXR-II compared with CXR-I. Other detected EV (miR-21 and miR-26a) and cellular (miR-31, miR-129-3p, miR-146a and miR-452) miRNA were not differentially expressed. The investigated miRNA did not reflect extrapulmonary involvement, but EV miR-146a and miR-150 were negatively correlated with pulmonary function (miR-146a with vital capacity (VC; Spearman's correlation coefficient (r(s)), P = -0.657, 0.007), percent predicted forced expiratory volume in 1 s (FEV1; -0.662, 0.006) and FEV1/forced vital capacity (FVC) ratio (-0.649, 0.008); miR-150 correlated negatively with VC (-0.584, 0.019) and FEV1/FVC ratio (-0.746, 0.001) in CXR-II cases). Conclusion Our data provide evidence that exosomes and microvesicles as extracellular vesicles are present in the bronchoalveolar space of sarcoidosis patients and they differentially express EV miRNA (miR-146a and miR-150), the expression of which correlates negatively with pulmonary function indices. The significance of these findings for disease pathophysiology and clinical course require further investigation.
引用
收藏
页码:1166 / 1172
页数:7
相关论文
共 50 条
  • [21] FIBROBLAST GROWTH-STIMULATING ACTIVITY IN BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH PULMONARY SARCOIDOSIS
    TANI, K
    YASUOKA, S
    OGUSHI, F
    NODA, Y
    ASADA, K
    OZAKI, T
    OGURA, T
    JAPANESE JOURNAL OF MEDICINE, 1990, 29 (06) : 576 - 582
  • [22] High concentrations of soluble Fas ligand in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
    Shikuwa, C
    Kadota, J
    Mukae, H
    Iwashita, T
    Kaida, H
    Ishii, H
    Ishimatsu, Y
    Kohno, S
    RESPIRATION, 2002, 69 (03) : 242 - 246
  • [23] Altered Extracellular Vesicle-Derived Protein and microRNA Signatures in Bronchoalveolar Lavage Fluid from Patients with Chronic Obstructive Pulmonary Disease
    Bartel, Sabine
    Wolters, Justina C.
    Noor, Hasnat
    Rafie, Karim
    Fang, Jiahua
    Kirchner, Benedikt
    Nolte-'t Hoen, Esther
    Pfaffl, Michael W.
    Rutgers, Steven
    Timens, Wim
    van den Berge, Maarten
    Hylkema, Machteld N.
    CELLS, 2024, 13 (11)
  • [24] Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis
    Bargagli, Elena
    Margollicci, Maria
    Perrone, Anna
    Luddi, Alice
    Perari, Maria Grazia
    Bianchi, Nicola
    Refini, Rosa Metella
    Grosso, Salvatore
    Volterrani, Luca
    Rottoli, Paola
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2007, 24 (01) : 59 - 64
  • [25] Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis
    Elena, Bargagli
    Antonietta, Margollicci Maria
    An-na, Perrone
    Alice, Luddi
    Grazia, Perari Maria
    Nicola, Bianchi
    Refini, Rosa Metella
    Salvatore, Grosso
    Luca, Volterrani
    Paola, Rottoli
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2006, 23 (02) : 159 - 159
  • [26] BRONCHOALVEOLAR LAVAGE CYTOLOGY IN PULMONARY SARCOIDOSIS
    ZAMAN, SS
    ELSHAMI, A
    GUPTA, PK
    ACTA CYTOLOGICA, 1995, 39 (06) : 1117 - 1123
  • [27] Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis
    Feng, Haoshen
    Yan, Lili
    Zhao, Yabin
    Li, Zhenhua
    Kang, Jian
    FRONTIERS IN MEDICINE, 2022, 8
  • [28] Increased Antifungal Antibodies in Bronchoalveolar Lavage Fluid and Serum in Pulmonary Sarcoidosis
    Suchankova, M.
    Paulovicova, E.
    Paulovicova, L.
    Majer, I.
    Tedlova, E.
    Novosadova, H.
    Tibenska, E.
    Tedla, M.
    Bucova, M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2015, 81 (04) : 259 - 264
  • [29] A Bronchoalveolar Lavage Fluid MicroRNA Signature Is Predictive for Survival in Patients with Idiopathic Pulmonary Fibrosis
    Schupp, J. C.
    Awad, K.
    Yan, X.
    Adams, T.
    Deluliis, G.
    Ahangari, F.
    Prasse, A.
    Kaminski, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [30] Antibacterial components in bronchoalveolar lavage fluid from healthy in individuals and sarcoidosis patients
    Agerberth, B
    Grunewald, J
    Castaños-Velez, E
    Olsson, B
    Jörnvall, H
    Wigzell, H
    Eklund, A
    Gudmundsson, GH
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (01) : 283 - 290